https://www.businesswire.com/news/home/20210902005442/en/The-McQuade-Center-for-Strategic-Research-and-Development-Enters-Agreement-with-Sentinel-Oncology-to-Develop-Breakthrough-Treatment-for-Fragile-X-Syndrome
The McQuade Center for Strategic Research and Development Enters Agreement with Sentinel Oncology...
The McQuade Center for Strategic Research and Development, LLC (MSRD), a member of the global Otsuka family of pharmaceutical companies, announces today that...
center for strategic research